Zynex monitoring announces first enrollment in a hemodialysis clinical trial for its fluid monitoring system

Englewood, colo. , dec. 20, 2021 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation and patient monitoring, today reported it has started enrollments in a hemodialysis clinical trial with its fluid monitoring system, cm-1500.
ZYXI Ratings Summary
ZYXI Quant Ranking